LSE:SN. (Smith & Nephew plc)

About SN.

Medical devices group Smith & Nephew makes nearly half of its revenues through its orthopaedics division, which manufactures knee joints, braces and other supports. Established in 1931, the group now has interests all over the world.

Smith & Nephew plc (LSE: SN.) Latest News

Investing Articles

2 healthcare stocks that could make you rich in 2017

These two companies offer bright futures at fair valuations.

Read more »

Investing Articles

What should growth investors buy for 2017?

Royston Wild looks at three of London’s hottest growth picks for 2017… and beyond.

Read more »

Investing Articles

2 hot growth shares to buy in December

Bilaal Mohamed explains why now could be a good time to buy these two growth stocks.

Read more »

Investing Articles

Should you invest in pills or joints?

Which of these stocks should be on your shopping list today?

Read more »

Investing Articles

Can this small-cap healthcare stock continue to beat big-cap rivals?

Roland Head looks at the latest results from a fast-growing healthcare business with strong overseas growth potential.

Read more »

Investing Articles

Is Ekf Diagnostics Holding plc a buy as shares jump 10%+?

Should you add Ekf Diagnostics Holding plc (LON: EKF) to your portfolio?

Read more »

Investing Articles

Are these top healthcare stocks in your portfolio?

These two healthcare stocks are attractive on long-term fundamentals.

Read more »

Investing Articles

Is this the best healthcare stock money can buy after today’s update?

Should you buy this stock or a sector peer following today's news?

Read more »

Investing Articles

2 ‘must-have’ healthcare stocks after today’s updates?

Should you pile into these two healthcare stocks right now?

Read more »

Investing Articles

Are these 3 shares simply the best Brexit buys after today’s results?

Could these stocks be a cure for Brexit blues?

Read more »

Investing Articles

3 growth stocks still worth buying: Shire plc, Smith & Nephew plc and Coca Cola HBC AG

Will Shire plc (LON:SHP), Smith & Nephew plc (LON:SN) and Coca Cola HBC AG (LON:CCH) meet their growth expectations?

Read more »

Investing Articles

GlaxoSmithKline plc vs Smith & Nephew plc: which is the FTSE 100’s best medical marvel?

Royston Wild considers whether investors should pile into FTSE 100 (INDEXFTSE: UKX) giants GlaxoSmithKline plc (LON: GSK) or Smith &…

Read more »